OraSure director granted 3,666 shares in fee stock
OraSure Technologies director Steven Kyle Boyd received a stock-based fee grant.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
OraSure Technologies director Steven Kyle Boyd received a stock-based fee grant. He was awarded 3,666 shares of common stock at a reference price of $4.4325 per share as a grant or award acquisition.
The footnote explains these are restricted shares granted under the OraSure Technologies, Inc. Stock Award Plan, with immediate vesting on the grant date. The shares were issued in lieu of cash director fees, at Boyd's election under the company's Director Compensation Policy. After this grant, he directly owns 163,234 common shares.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 3,666 | $4.4325 | $16K |
Footnotes (1)
- F1. Grant of restricted shares under the OraSure Technologies, Inc. Stock Award Plan, with immediate vesting on date of grant. Shares issued in lieu of cash fees at Reporting Person's election under the Company's Director Compensation Policy.
Key Figures
Key Terms
Stock Award Plan financial
Director Compensation Policy financial
grant or award acquisition financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did OraSure Technologies (OSUR) director Steven Kyle Boyd report on this Form 4?
Was the OraSure Technologies (OSUR) Form 4 transaction an open-market buy or a compensation grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.